<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ecotropic <z:mp ids='MP_0001799'>viral</z:mp> integration site 1 (Evi1) is one of the master regulators in the development of <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>High expression of Evi1 is found in 10% of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and indicates a poor outcome </plain></SENT>
<SENT sid="2" pm="."><plain>Several recent studies have indicated that Evi1 requires collaborative factors to induce <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, the search for candidate factors that collaborate with Evi1 in <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> is one of the key issues in uncovering the mechanism of Evi1-related <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Previously, we succeeded in making a mouse model of Evi1-related <z:hpo ids='HP_0001909'>leukemia</z:hpo> using a bone marrow transplantation (BMT) system </plain></SENT>
<SENT sid="5" pm="."><plain>In the Evi1-induced leukemic cells, we identified frequent retroviral integrations near the CCAAT/enhancer-binding protein β (C/EBPβ) gene and overexpression of its protein </plain></SENT>
<SENT sid="6" pm="."><plain>These findings imply that C/EBPβ is a candidate gene that collaborates with Evi1 in <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Cotransduction of Evi1 and the shortest isoform of C/EBPβ, liver inhibitory protein (LIP), induced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with short latencies in a mouse BMT model </plain></SENT>
<SENT sid="8" pm="."><plain>Overexpression of LIP alone also induced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with longer latencies </plain></SENT>
<SENT sid="9" pm="."><plain>However, excision of <z:hpo ids='HP_0000001'>all</z:hpo> 3 isoforms of C/EBPβ (LAP*/LAP/LIP) did not inhibit the development of Evi1-induced <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Therefore, isoform-specific intervention that targets LIP is required when we consider C/EBPβ as a therapeutic target </plain></SENT>
</text></document>